Torriani Martin, Thomas Bijoy J, Halpern Elkan F, Jensen Megan E, Rosenthal Daniel I, Palmer William E
Division of Musculoskeletal Imaging and Institute for Technology Assessment, Massachusetts General Hospital and Harvard Medical School, 15 Parkman St, WACC 515, Boston, MA 02114, USA.
Radiology. 2005 Aug;236(2):609-14. doi: 10.1148/radiol.2362041661.
To prospectively determine the repeatability and variability of tibialis anterior intramyocellular lipid (IMCL) quantifications performed by using 1.5-T hydrogen 1 (1H) magnetic resonance (MR) spectroscopy in healthy subjects.
Institutional review board approval and written informed consent were obtained for this Health Insurance Portability and Accountability Act-compliant study. The authors examined the anterior tibial muscles of 27 healthy subjects aged 19-48 years (12 men, 15 women; mean age, 25 years) by using single-voxel short-echo-time point-resolved 1H MR spectroscopy. During a first visit, the subjects underwent 1H MR spectroscopy before and after being repositioned in the magnet bore, with voxels carefully placed on the basis of osseous landmarks. Measurements were repeated after a mean interval of 12 days. All spectra were fitted by using Java-based MR user interface (jMRUI) and LCModel software, and lipid peaks were scaled to the unsuppressed water peak (at 4.7 ppm) and the total creatine peak (at approximately 3.0 ppm). A one-way random-effects variance components model was used to determine intraday and intervisit coefficients of variation (CVs). A power analysis was performed to determine the detectable percentage change in lipid measurements for two subject sample sizes.
Measurements of the IMCL methylene protons peak at a resonance of 1.3 ppm scaled to the unsuppressed water peak (IMCL(W)) that were obtained by using jMRUI software yielded the lowest CVs overall (intraday and intervisit CVs, 13.4% and 14.4%, respectively). The random-effects variance components model revealed that nonbiologic factors (equipment and repositioning) accounted for 50% of the total variability in IMCL quantifications. Power analysis for a sample size of 20 subjects revealed that changes in IMCL(W) of greater than 15% could be confidently detected between 1H MR spectroscopic measurements obtained on different days.
1H MR spectroscopy is feasible for repeatable quantification of IMCL concentrations in longitudinal studies of muscle metabolism.
前瞻性地确定在健康受试者中使用1.5-T氢质子(1H)磁共振(MR)波谱对胫前肌细胞内脂质(IMCL)进行定量分析的可重复性和变异性。
本符合《健康保险流通与责任法案》的研究获得了机构审查委员会的批准和书面知情同意书。作者使用单体素短回波时间点分辨1H MR波谱检查了27名年龄在19至48岁之间的健康受试者(12名男性,15名女性;平均年龄25岁)的胫前肌。在首次就诊期间,受试者在重新定位到磁体孔内前后均接受了1H MR波谱检查,并根据骨性标志小心放置体素。平均间隔12天后重复测量。所有波谱均使用基于Java的MR用户界面(jMRUI)和LCModel软件进行拟合,脂质峰按未抑制水峰(4.7 ppm)和总肌酸峰(约3.0 ppm)进行标度。使用单向随机效应方差成分模型确定日内和访间变异系数(CV)。进行了功效分析,以确定两种受试者样本量下脂质测量中可检测到的百分比变化。
使用jMRUI软件获得的在1.3 ppm共振处标度到未抑制水峰的IMCL亚甲基质子峰测量值(IMCL(W))总体上具有最低的CV(日内和访间CV分别为13.4%和14.4%)。随机效应方差成分模型显示,非生物学因素(设备和重新定位)占IMCL定量分析总变异性的50%。对20名受试者样本量的功效分析表明,在不同日期获得的1H MR波谱测量之间,可以可靠地检测到IMCL(W)变化大于15%。
在肌肉代谢的纵向研究中,1H MR波谱对于IMCL浓度的可重复定量分析是可行的。